Why are we selling now Mr Chairman?

I'm a No voter, Mr Chairman but just in case I missed something:

I've accessed the transcript of the Investor Webinar from 30-10-24 just so that I could read what your Executives have been saying about the company, Mr Chairman. This is just a small sample, verbatim, for you Mr Chairman, just in case you missed the memo. I could send them to you, but I know you're too busy to answer any of the emails that I have already sent to you.

• “...but we've changed the business and we believe it's in a strong turnaround position for rapid growth in both dermatology and women's health in the United States.” CEO

• Referencing WH products “...So we certainly feel very confident in where Mayne Pharma sits today and what the future looks like.” C. Turner VP Women’s Health

• Speaking about dermatology and channel strategy “...We're on track to ship over 1 million units in the 2024 calendar year. So in total, our portfolio growth strategy with our field force carrying over 20 products has achieved a 900% growth in units during this time period, and this is only the beginning.” M. Gambill VP Dermatology Sales

• Speaking about disintermediation “...And then what we referred to more recently is full disintermediation, is what we're really excited about going on in FY24 and beyond.” D. Moore Executive VP

• “...But the good point is, in both segments, Mayne Pharma is growing faster than the market for both dermatology and women's health, dramatically.” CEO

• “Thankfully, we have world-class products that do make a difference in our patients' lives, and obviously a world-class access program” D. Moore Executive VP

• Speaking about WH products “...They're early in their onset and we have lots of headroom to drive significant growth for all 4 brands. Annovera, Nextstellis, Bijuva and Imvexxy.” CEO

• “...And what we have been able to do through the channel strategy is actually be able to sell a medical prescription dermatology product for cash and make money. Nobody else has ever done that. And that's a difference.” CEO

• Concluding remarks “...And this is gonna help us to continue this remarkable turnaround that we've had so far and surprise the market with our continuous growth and profitability” CEO